ALLO – Knox Daily

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics

Insiders Updates

Allogene Therapeutics Inc’s filing revealed that its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $19916.0 on Dec 09

Insiders Updates

In a filing, Allogene Therapeutics Inc revealed its Director MESSEMER DEBORAH M. unloaded Company’s shares for reported $19916.0 on Dec

Analysts Viewpoint

Allogene Therapeutics Inc’s recent filing unveils that its Officer Parker Geoffrey M. acquired Company’s shares for reported $0.1 million on

Analysts Viewpoint

Allogene Therapeutics Inc’s filing revealed that its Officer Parker Geoffrey M. acquired Company’s shares for reported $0.1 million on Oct

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

Allogene Therapeutics Inc’s recent filing unveils that its Officer Parker Geoffrey M. acquired Company’s shares for reported $0.1 million on

Insiders Updates

Allogene Therapeutics Inc’s filing revealed that its Officer Parker Geoffrey M. acquired Company’s shares for reported $0.1 million on Oct

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: ALLO